Utilizing the power of immunotherapy, this atezolizumab injection Tecentriq collaborates with your body's built-in defenses to successfully combat cancer cells. It was created especially for cancer patients with advanced or metastatic disease, giving them new hope and a chance for better results. This Atezolizumab Injection Tecentriq suppresses PD-L1, a protein that cancer cells can utilize to avoid the immune system, using a special method of action. The immune system's capacity to identify and combat cancer cells is unleashed.
Product details
Available Dose |
1 vial of 20 ml concentrate |
Company Name |
Hoffman La Roche Ltd. |
Dosage Form |
Injection |
Packaging |
Box |
Brand |
Rx |
Manufacturer |
Hoffman La Roche Ltd. |
DHEER HEALTHCARE PRIVATE LIMITED
All Rights Reserved.(Terms of Use) Developed and Managed by Infocom Network Private Limited. |